Other Species / Isoforms
  NDRG3 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K13-ub
DVQLTEIkPLLNDKN
0 1
NDRG3 (human) DVQLTEIkPLLNDKN K13-ub
NDRG3 iso2 (human) DVQLTEIKPLLNDKE K13
NDRG3 iso3 (human) DVQLTEIKPLLNDKN K13
NDRG3 (mouse) DVQLTEIKPLLNDkN K13
NDRG3 (rat) DVQLTEIKPLLNDKN K13
K19
IkPLLNDKNGTRNFQ
0 1
NDRG3 (human) IkPLLNDKNGTRNFQ K19
NDRG3 iso2 (human) IKPLLNDKEHDIETT K19
NDRG3 iso3 (human) IKPLLNDKNGTRNFQ K19
NDRG3 (mouse) IKPLLNDkNGTRNFQ K19-ub
NDRG3 (rat) IKPLLNDKNGTRNFQ K19
K51
VTIRGLPKGNRPVIL
0 1
NDRG3 (human) VTIRGLPKGNRPVIL K51
NDRG3 iso2 (human) VTIRGLPKGNRPVIL K39
NDRG3 iso3 (human) gap -
NDRG3 (mouse) VTIRGLPkGNRPVIL K51-ub
NDRG3 (rat) VTIRGLPKGNRPVIL K51
K286-ub
PINTTLLkMADCGGL
0 1
NDRG3 (human) PINTTLLkMADCGGL K286-ub
NDRG3 iso2 (human) PINTTLLKMADCGGL K274
NDRG3 iso3 (human) PINTTLLKMADCGGL K197
NDRG3 (mouse) PINTTLLKMADCGGL K286
NDRG3 (rat) PINTTLLKMADCGGL K286
Y308-p
KLTEAFKyFLQGMGY
0 1
NDRG3 (human) KLTEAFKyFLQGMGY Y308-p
NDRG3 iso2 (human) KLTEAFKYFLQGMGY Y296
NDRG3 iso3 (human) KLTEAFKYFLQGMGY Y219
NDRG3 (mouse) KLTEAFKYFLQGMGY Y308
NDRG3 (rat) KLTEAFKYFLQGMGy Y308
Y315
yFLQGMGYIPsAsMt
0 7
NDRG3 (human) yFLQGMGYIPsAsMt Y315
NDRG3 iso2 (human) YFLQGMGYIPSASMT Y303
NDRG3 iso3 (human) YFLQGMGYIPSASMT Y226
NDRG3 (mouse) YFLQGMGYIPsAsMt Y315
NDRG3 (rat) YFLQGMGyIPSASMT Y315-p
S318-p
QGMGYIPsAsMtRLA
0 3
NDRG3 (human) QGMGYIPsAsMtRLA S318-p
NDRG3 iso2 (human) QGMGYIPSASMTRLA S306
NDRG3 iso3 (human) QGMGYIPSASMTRLA S229
NDRG3 (mouse) QGMGYIPsAsMtRLA S318-p
NDRG3 (rat) QGMGyIPSASMTRLA S318
S320-p
MGYIPsAsMtRLARs
0 4
NDRG3 (human) MGYIPsAsMtRLARs S320-p
NDRG3 iso2 (human) MGYIPSASMTRLARS S308
NDRG3 iso3 (human) MGYIPSASMTRLARS S231
NDRG3 (mouse) MGYIPsAsMtRLARs S320-p
NDRG3 (rat) MGyIPSASMTRLARS S320
T322-p
YIPsAsMtRLARsRt
0 3
NDRG3 (human) YIPsAsMtRLARsRt T322-p
NDRG3 iso2 (human) YIPSASMTRLARSRT T310
NDRG3 iso3 (human) YIPSASMTRLARSRT T233
NDRG3 (mouse) YIPsAsMtRLARsRt T322-p
NDRG3 (rat) yIPSASMTRLARSRt T322
S327-p
sMtRLARsRtHstss
Upstream
0 196
Treatment
  • Su11274
  • wortmannin
NDRG3 (human) sMtRLARsRtHstss S327-p
NDRG3 iso2 (human) SMTRLARSRTHSTSS S315
NDRG3 iso3 (human) SMTRLARSRTHSTSS S238
NDRG3 (mouse) sMtRLARsRtHstss S327-p
NDRG3 (rat) SMTRLARSRtHsTss S327
T329-p
tRLARsRtHstsssL
Upstream
0 162
Treatment
  • dasatinib
  • EGF
  • gefitinib
  • SB202190
  • Su11274
  • wortmannin
NDRG3 (human) tRLARsRtHstsssL T329-p
NDRG3 iso2 (human) TRLARSRTHSTSSSL T317
NDRG3 iso3 (human) TRLARSRTHSTSSSL T240
NDRG3 (mouse) tRLARsRtHstsssI T329-p
NDRG3 (rat) TRLARSRtHsTsssI T329-p
S331-p
LARsRtHstsssLGs
Upstream
0 702
Treatment
  • anti-CD3
  • dasatinib
  • EGF
  • gefitinib
  • metastatic potential
  • selumetinib
  • Su11274
  • wortmannin
NDRG3 (human) LARsRtHstsssLGs S331-p
NDRG3 iso2 (human) LARSRTHSTSSSLGS S319
NDRG3 iso3 (human) LARSRTHSTSSSLGS S242
NDRG3 (mouse) LARsRtHstsssIGs S331-p
NDRG3 (rat) LARSRtHsTsssIGs S331-p
T332-p
ARsRtHstsssLGsG
Upstream
0 169
Treatment
  • anti-CD3
  • wortmannin
NDRG3 (human) ARsRtHstsssLGsG T332-p
NDRG3 iso2 (human) ARSRTHSTSSSLGSG T320
NDRG3 iso3 (human) ARSRTHSTSSSLGSG T243
NDRG3 (mouse) ARsRtHstsssIGsG T332-p
NDRG3 (rat) ARSRtHsTsssIGsG T332
S333-p
RsRtHstsssLGsGE
Upstream
0 173
Treatment
  • Su11274
  • wortmannin
NDRG3 (human) RsRtHstsssLGsGE S333-p
NDRG3 iso2 (human) RSRTHSTSSSLGSGE S321
NDRG3 iso3 (human) RSRTHSTSSSLGSGE S244
NDRG3 (mouse) RsRtHstsssIGsGE S333-p
NDRG3 (rat) RSRtHsTsssIGsGE S333-p
S334-p
sRtHstsssLGsGEs
Upstream
0 402
Treatment
  • angiotensin_2
  • gefitinib
  • lapatinib
  • selumetinib
  • Su11274
  • wortmannin
NDRG3 (human) sRtHstsssLGsGEs S334-p
NDRG3 iso2 (human) SRTHSTSSSLGSGES S322
NDRG3 iso3 (human) SRTHSTSSSLGSGES S245
NDRG3 (mouse) sRtHstsssIGsGEs S334-p
NDRG3 (rat) SRtHsTsssIGsGEs S334-p
S335-p
RtHstsssLGsGEsP
Upstream
0 432
Treatment
  • angiotensin_2
  • gefitinib
  • Su11274
  • wortmannin
NDRG3 (human) RtHstsssLGsGEsP S335-p
NDRG3 iso2 (human) RTHSTSSSLGSGESP S323
NDRG3 iso3 (human) RTHSTSSSLGSGESP S246
NDRG3 (mouse) RtHstsssIGsGEsP S335-p
NDRG3 (rat) RtHsTsssIGsGEsP S335-p
S338-p
stsssLGsGEsPFsR
Upstream
0 92
Treatment
  • Su11274
NDRG3 (human) stsssLGsGEsPFsR S338-p
NDRG3 iso2 (human) STSSSLGSGESPFSR S326
NDRG3 iso3 (human) STSSSLGSGESPFSR S249
NDRG3 (mouse) stsssIGsGEsPFSR S338-p
NDRG3 (rat) sTsssIGsGEsPFSR S338-p
S341-p
ssLGsGEsPFsRsVt
Upstream
0 33
Treatment
  • BI2536
  • MLN8054
NDRG3 (human) ssLGsGEsPFsRsVt S341-p
NDRG3 iso2 (human) SSLGSGESPFSRSVT S329
NDRG3 iso3 (human) SSLGSGESPFSRSVT S252
NDRG3 (mouse) ssIGsGEsPFSRSVT S341-p
NDRG3 (rat) ssIGsGEsPFSRSVT S341-p
S344-p
GsGEsPFsRsVtsNQ
0 3
NDRG3 (human) GsGEsPFsRsVtsNQ S344-p
NDRG3 iso2 (human) GSGESPFSRSVTSNQ S332
NDRG3 iso3 (human) GSGESPFSRSVTSNQ S255
NDRG3 (mouse) GsGEsPFSRSVTSNQ S344
NDRG3 (rat) GsGEsPFSRSVTSNQ S344
S346-p
GEsPFsRsVtsNQsD
0 6
NDRG3 (human) GEsPFsRsVtsNQsD S346-p
NDRG3 iso2 (human) GESPFSRSVTSNQSD S334
NDRG3 iso3 (human) GESPFSRSVTSNQSD S257
NDRG3 (mouse) GEsPFSRSVTSNQsD S346
NDRG3 (rat) GEsPFSRSVTSNQSD S346
T348-p
sPFsRsVtsNQsDGt
0 12
NDRG3 (human) sPFsRsVtsNQsDGt T348-p
NDRG3 iso2 (human) SPFSRSVTSNQSDGT T336
NDRG3 iso3 (human) SPFSRSVTSNQSDGT T259
NDRG3 (mouse) sPFSRSVTSNQsDGt T348
NDRG3 (rat) sPFSRSVTSNQSDGT T348
S349-p
PFsRsVtsNQsDGtQ
0 14
NDRG3 (human) PFsRsVtsNQsDGtQ S349-p
NDRG3 iso2 (human) PFSRSVTSNQSDGTQ S337
NDRG3 iso3 (human) PFSRSVTSNQSDGTQ S260
NDRG3 (mouse) PFSRSVTSNQsDGtQ S349
NDRG3 (rat) PFSRSVTSNQSDGTQ S349
S352-p
RsVtsNQsDGtQEsC
0 40
NDRG3 (human) RsVtsNQsDGtQEsC S352-p
NDRG3 iso2 (human) RSVTSNQSDGTQESC S340
NDRG3 iso3 (human) RSVTSNQSDGTQESC S263
NDRG3 (mouse) RSVTSNQsDGtQEsC S352-p
NDRG3 (rat) RSVTSNQSDGTQESC S352
T355-p
tsNQsDGtQEsCEsP
Upstream
0 14
Treatment
  • UV
NDRG3 (human) tsNQsDGtQEsCEsP T355-p
NDRG3 iso2 (human) TSNQSDGTQESCESP T343
NDRG3 iso3 (human) TSNQSDGTQESCESP T266
NDRG3 (mouse) TSNQsDGtQEsCEsP T355-p
NDRG3 (rat) TSNQSDGTQESCESP T355
S358-p
QsDGtQEsCEsPDVL
0 4
NDRG3 (human) QsDGtQEsCEsPDVL S358-p
NDRG3 iso2 (human) QSDGTQESCESPDVL S346
NDRG3 iso3 (human) QSDGTQESCESPDVL S269
NDRG3 (mouse) QsDGtQEsCEsPDVL S358-p
NDRG3 (rat) QSDGTQESCESPDVL S358
S361-p
GtQEsCEsPDVLDRH
Upstream
0 108
Treatment
  • MLN8054
  • rapamycin
NDRG3 (human) GtQEsCEsPDVLDRH S361-p
NDRG3 iso2 (human) GTQESCESPDVLDRH S349
NDRG3 iso3 (human) GTQESCESPDVLDRH S272
NDRG3 (mouse) GtQEsCEsPDVLDRH S361-p
NDRG3 (rat) GTQESCESPDVLDRH S361
T370-p
DVLDRHQtMEVsC__
Upstream
0 18
Treatment
  • Su11274
NDRG3 (human) DVLDRHQtMEVsC__ T370-p
NDRG3 iso2 (human) DVLDRHQTMEVSC__ T358
NDRG3 iso3 (human) DVLDRHQTMEVSC__ T281
NDRG3 (mouse) DVLDRHQTMEVsC__ T370
NDRG3 (rat) DVLDRHQTMEVSC__ T370
S374-p
RHQtMEVsC______
0 10
NDRG3 (human) RHQtMEVsC______ S374-p
NDRG3 iso2 (human) RHQTMEVSC______ S362
NDRG3 iso3 (human) RHQTMEVSC______ S285
NDRG3 (mouse) RHQTMEVsC______ S374-p
NDRG3 (rat) RHQTMEVSC______ S374